Catalent receives P&G External Business Partner of the Year Award

19 Feb 2019

The award recognizes the performance of Catalent’s two state-of-the-art softgel manufacturing facilities in Ontario, Canada.

Catalent Pharma Solutions has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the External Business Partner of the Year Award.

Catalent receives P&G External Business Partner of the Year Award

The award recognizes the performance of Catalent’s two state-of-the-art softgel manufacturing facilities in Ontario, Canada which have been supplying P&G Personal Healthcare brands in the US and Canada. Catalent also launched additional cough and cold OTC product line extensions with P&G in 2018, which are supplied from Catalent’s facilities in Ontario.

“Catalent has been P&G’s preferred softgel supplier for 20 years,” commented Dr Aris Gennadios, President, Catalent Softgel Technologies. He added: “We continue to collaborate closely with P&G Personal Healthcare to bring innovative products to consumers.”

“I congratulate and thank all of our award winners. They are critical partners in accomplishing our purpose,” said Stew Atkinson, Chief Purchasing Officer, P&G. “P&G’s supplier eco-systems are creating value for consumers, customers, P&G and our suppliers. I am proud of what we have accomplished, and we will continue to raise the bar on superiority, productivity and citizenship together.”

Catalent’s Ontario facilities in Strathroy and Windsor offer softgel development and manufacturing capabilities for both the pharmaceutical and consumer health industries. The two sites combine integrated formulation, manufacturing, analytical and packaging services to provide full-service turnkey solutions to partners.

Read More

Related news

Recipharm expands Indian injectable dosage form capabilities

Recipharm expands Indian injectable dosage form capabilities

7 Nov 2019

Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.

Read more 
Aptar acquires a leader in drug delivery training devices and patient onboarding

Aptar acquires a leader in drug delivery training devices and patient onboarding

6 Nov 2019

Acquisition reflects movement of treatments being administered by patients at home rather than by healthcare providers.

Read more 
Europe predicted to surpass the US in biologic manufacturing capacity by 2023

Europe predicted to surpass the US in biologic manufacturing capacity by 2023

6 Nov 2019

Demand for biological manufacturing is growing faster than capacity growth.

Read more 
SP acquires Spain based global provider of complete sterile filling lines

SP acquires Spain based global provider of complete sterile filling lines

5 Nov 2019

Company's strategic move reflects its expectation of short-run aseptic liquid filling to continue to drive pharmaceutical growth.

Read more 
Legacy recruits heavily to meet growing steriles demand

Legacy recruits heavily to meet growing steriles demand

5 Nov 2019

Company to reach 250 employees by year end to meet growing drug product manufacturing demand.

Read more 
China on course for 'massive' bio capacity shortfall

China on course for 'massive' bio capacity shortfall

4 Nov 2019

A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand.

Read more 
Recipharm launches new service to support companies with QC and analytical requirements

Recipharm launches new service to support companies with QC and analytical requirements

1 Nov 2019

Services including method development, method validation, and stability program design and implementation.

Read more 
Evonetix expands to develop its desktop DNA synthesis platform

Evonetix expands to develop its desktop DNA synthesis platform

31 Oct 2019

15,000 sq. ft of laboratory and office space will enable continued growth and development of the company’s integrated desktop platform for DNA synthesis.

Read more 
The way forward? Collaborate with robots

The way forward? Collaborate with robots

30 Oct 2019

Vetter increasingly relies on close interaction of humans and machines for greater flexibility.

Read more 
The benefits of transitioning from paper-based to paperless batch record management

The benefits of transitioning from paper-based to paperless batch record management

29 Oct 2019

Free webinar to discuss the benefits of a collaborative approach to implementing an electronic batch record platform.

Read more